On February 24, we participated in the meeting
Europe Next 2050
inaugurated by the Secretary of State for Trade, Xiana Mèndez, where we contributed with our vision of biotechnology at the discussion table on the
Industry 4.0
. Our CEO and founder, Juan Carlos Gregorio, has presented relevant topics such as:

  • The effectiveness of financial instruments for biotechnology companies will mean efficiency in obtaining breakthrough drugs for Spanish healthcare. for the Spanish healthcare system.
  • Treatments against cytokine storm, or pancreatitis or cancer in solid tumors such as the pancreas could depend on this funding.
  • Biotechnology generates jobs and exports high value-added products.

The event was covered by the European Commission office, all participating organizations and associations, as well as the media.